by Cornell University Researchers from Cornell University have identified a possible target for antiviral treatment for COVID-19. The researchers initially set out to analyze the structure and characteristics of SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (Middle East respiratory syndrome coronavirus), with a focus on the spike protein—specifically the fusion peptide—that allows these viruses...
